Genetic Disorders
Angelman Syndrome
안젤만증후군
Maternal 15q11-q13 deletion or paternal UPD - happy demeanor, seizures, developmental delay (imprinting)
- How common
- Rare but important
- Typical age
- Often pediatric/young adult onset
What is it?
Genetic cause and core pathophysiology of Angelman Syndrome (Imprinting disorder (maternal 15q11-q13 deletion)).
Commonly affected: brain
How it develops
- Genetic mutationImprinting disorder (maternal 15q11-q13 deletion) pattern mutation
- Protein/enzyme defectDefective protein loses normal function
- Cellular consequenceTissue-specific changes occur in brain
- Clinical manifestationCharacteristic clinical features appear
Symptoms
- Characteristic featuresClassic Angelman Syndrome presentation
- Organ-specific complicationsbrain involvement
- Progressive courseMay worsen over time
How it is examined
- History + pedigreeConfirm inheritance pattern
- Physical examIdentify specific phenotype
- Genetic testing (confirmatory)Confirm Imprinting disorder (maternal 15q11-q13 deletion) mutation
Imaging
Imaging of affected organ as indicated.
- Disease-specific findings
MRI/CT to assess organ involvement when needed.
- Organ involvement
Non-surgical care
- Genetic counselingPatient + family counseling, prenatal options
- Symptomatic careTargeted symptom management
- Multidisciplinary follow-upCoordinate specialist care
- Enzyme/protein replacement (if applicable)ERT or analogous therapies
Conservative options are generally tried first. Medications listed here can have side effects — discuss them with your prescriber.
When surgery is considered
For complications or targeted therapy
Procedures that may be discussed
- Targeted pharmacotherapy (if available)
- Gene therapy (if available)
- Surgery for complications
Outlook
Early diagnosis and management improve quality of life.